“I tried to find out how to get this [reversing MS with stem cells] done and all the companies I called require you to pay $15,000 for stem cells they already have and go to Mexico for the procedure. I wanted to use the baby’s cord tissue stem cells”
Posts Tagged ‘storage’
The very latest development in the private stem cell storage industry is a US company offering the private storage of embryonic stem cells. This service is offered to people who have excess frozen human embryos stored in infertility clinics. Such embryos are thawed, embryonic stem cells extracted and the resultant cells re-frozen for possible later use by the clients.
On the face of it this might sound like a useful service but there are many objections to such a service including:
# Embryonic stem cells have no current clinical applications. There are no plans at all for clinical trials involving embryonic stem cells.
# The current technology for the derivation of embryonic stem cells will no doubt improve with time making derivation at this point in time potentially damaging
# Much more research is needed before there is any justification at all for such a service
# In the event that the clients need their frozen embryos (for example the death of a child) then this option will have been taken away from them and the creation of further new embryos might not be possible
# There are still many technical problems to be resolved not least the problem of cell stability and tumor formation by embryonic stem cells
# Current adult and cord blood stem cell technology is providing current therapy and clinical trials in regenerative medicine
Bio-Matrix Scientific Group Inc. :: NIH News Confirms Trend in Stem Cell ‘Storage’ Facilities, says CEO of San Diego-based Bio-Matrix Scientific GroupIn ALL ARTICLES, STEM CELLS IN THE NEWS on March 27, 2009 at 3:36 pm
NIH News Confirms Trend in Stem Cell ‘Storage’ Facilities, says CEO of San Diego-based Bio-Matrix Scientific Group
SAN DIEGO, March 26 /PRNewswire-FirstCall/ — David Koos, Chairman and CEO of San Diego-based Bio-Matrix Scientific Group, Inc. (OTCBulletinBoard: BMSN) announced today that the important discovery reported on Wednesday, March 25 by researchers at the National Institutes of Health (NIH; http://www.nih.gov), which has implications for Leukemia treatment and artificially culturing blood cells, validates a new direction for stem cell “storage” facilities that meet rigid state and federal regulatory requirements. The researchers deciphered a key sequence of events governing whether the stem cells that produce red and white blood cells remain anchored to the bone marrow, or migrate into the circulatory system – an important discovery that will advance understanding of how blood cells and immune cells are generated.
“The findings of NIH researchers have implications for culturing infection-fighting immune cells outside the body, where they could be temporarily held in storage during chemotherapy and other treatments which suppress the immune system. This discovery confirms a new trend for commercial stem cell storage facilities for research and treatment of diseases, and their important role in public and private stem cell research efforts now and into the future,” said Koos.